Last reviewed · How we verify
NCT05100875: SSERT
Social Skills and Emotion Regulation Training "SSERT" for Trauma in Psychosis
NA trial testing Social Skills and Emotion Regulation Training "SSERT" in Psychosis in 19 participants. Completed in 31 March 2024.
31 December 2023
Quick facts
| Lead sponsor | Douglas Mental Health University Institute |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 19 |
| Start date | 1 July 2021 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 March 2024 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Social Skills and Emotion Regulation Training "SSERT"
Conditions studied
- Psychosis — all drugs for Psychosis →
- Trauma — all drugs for Trauma →
- Emotion Regulation — all drugs for Emotion Regulation →
Sponsor
Douglas Mental Health University Institute
Who can join
18 and older, any sex, with Psychosis or Trauma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will investigate if the SSERT (Social Skills and Emotion Regulation Training) intervention is feasible and acceptable in individual with psychotic disorder and a history of trauma.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05100875
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Psychosis
Currently open trials in the same condition.
- NCT07213492 — Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder · NA · recruiting
- NCT07056894 — Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis · NA · recruiting
- NCT07395206 — Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Dis · NA · recruiting
- NCT07196462 — Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia · NA · recruiting
- NCT07364825 — Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care · NA · recruiting
Other Douglas Mental Health University Institute trials
Trials by the same sponsor.
- NCT07002996 — Spatial Memory Training and Cognitive Function · NA · recruiting
- NCT06978465 — DIALOG: Understanding Disorganisation: A Language-focused Global Initiative in Psychosis · not yet recruiting
- NCT06978452 — Behavioural Development, Long-term Outcomes and Opportunities to Optimize Youth Mental Health Trajectories · recruiting
- NCT06978894 — Predicting Psychotic Relapse Using Speech-Based Early Detection · recruiting
- NCT06893393 — Virtual Travel Into Nature for Individuals With Lived Experience of Severe Mental Disorders · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05100875 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Douglas Mental Health University Institute
- Last refreshed: 27 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05100875.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing